Therefore, they used 3TSR (Thrombospondin-1 three-type 1 repeat, collectively referred to as 3TSR) to induce tumor regression and normalize tumor vasculature before administration of oncolytic NDV. This evidence concerns the gene THBS1 and neoplasm.